Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lurdes Zamora

Showing results (21-30 of 70) with videos related to

Pageof 7
Sort By:
Epigenetics|November 22, 2017
DNA methylation profile in chronic myelomonocytic leukemia associates with distinct clinical, biological and genetic featuresLaura Palomo, Roberto Malinverni, Marta Cabezón, et al.
Scientific Reports|October 28, 2021
Divergent leukaemia subclones as cellular models for testing vulnerabilities associated with gains in chromosomes 7, 8 or 18Michael Maher, Jeannine Diesch, Marguerite-Marie Le Pannérer, et al.
European Journal of Haematology|December 31, 2015
Highly variable mutational profile of ASXL1 in myelofibrosisMarc Sorigué, Josep-Maria Ribera, Olga García, et al.
Journal of Clinical Medicine|October 27, 2022
Association between Germline Single-Nucleotide Variants in ADME Genes and Major Molecular Response to Imatinib in Chronic Myeloid Leukemia PatientsNatalia Estrada, Lurdes Zamora, Francisca Ferrer-Marín, et al.
Blood|June 24, 2020
Molecular landscape and clonal architecture of adult myelodysplastic/myeloproliferative neoplasmsLaura Palomo, Manja Meggendorfer, Stephan Hutter, et al.
Oncotarget|May 4, 2018
Impact of mutational studies on the diagnosis and the outcome of high-risk myelodysplastic syndromes and secondary acute myeloid leukemia patients treated with 5-azacytidineMarta Cabezón, Joan Bargay, Blanca Xicoy, et al.
Medicina Clinica|July 22, 2025
Prognostic impact of cytogenetic alterations in newly diagnosed acute myeloid leukemia treated with risk-adapted protocolsNeus Ruiz-Xivillé, Mireia Morgades, Laura Blanco, et al.
Cytometry. Part B, Clinical Cytometry|November 30, 2022
Optimization of monocyte gating to quantify monocyte subsets for the diagnosis of chronic myelomonocytic leukemiaRebeca Jurado, Maria Huguet, Blanca Xicoy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2005
Activating mutations in the tyrosine kinase domain of the epidermal growth factor receptor are associated with improved survival in gefitinib-treated chemorefractory lung adenocarcinomasMiguel Taron, Yukito Ichinose, Rafael Rosell, et al.
Hematological Oncology|September 3, 2019
m7FLIPI and targeted sequencing in high-risk follicular lymphomaMarc Sorigue, Anna Oliveira, Santiago Mercadal, et al.
Pageof 7

Showing results (21-30 of 70) with videos related to

Sort By:
Pageof 7
Epigenetics|November 22, 2017
DNA methylation profile in chronic myelomonocytic leukemia associates with distinct clinical, biological and genetic featuresLaura Palomo, Roberto Malinverni, Marta Cabezón, et al.
Scientific Reports|October 28, 2021
Divergent leukaemia subclones as cellular models for testing vulnerabilities associated with gains in chromosomes 7, 8 or 18Michael Maher, Jeannine Diesch, Marguerite-Marie Le Pannérer, et al.
European Journal of Haematology|December 31, 2015
Highly variable mutational profile of ASXL1 in myelofibrosisMarc Sorigué, Josep-Maria Ribera, Olga García, et al.
Journal of Clinical Medicine|October 27, 2022
Association between Germline Single-Nucleotide Variants in ADME Genes and Major Molecular Response to Imatinib in Chronic Myeloid Leukemia PatientsNatalia Estrada, Lurdes Zamora, Francisca Ferrer-Marín, et al.
Blood|June 24, 2020
Molecular landscape and clonal architecture of adult myelodysplastic/myeloproliferative neoplasmsLaura Palomo, Manja Meggendorfer, Stephan Hutter, et al.
Oncotarget|May 4, 2018
Impact of mutational studies on the diagnosis and the outcome of high-risk myelodysplastic syndromes and secondary acute myeloid leukemia patients treated with 5-azacytidineMarta Cabezón, Joan Bargay, Blanca Xicoy, et al.
Medicina Clinica|July 22, 2025
Prognostic impact of cytogenetic alterations in newly diagnosed acute myeloid leukemia treated with risk-adapted protocolsNeus Ruiz-Xivillé, Mireia Morgades, Laura Blanco, et al.
Cytometry. Part B, Clinical Cytometry|November 30, 2022
Optimization of monocyte gating to quantify monocyte subsets for the diagnosis of chronic myelomonocytic leukemiaRebeca Jurado, Maria Huguet, Blanca Xicoy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2005
Activating mutations in the tyrosine kinase domain of the epidermal growth factor receptor are associated with improved survival in gefitinib-treated chemorefractory lung adenocarcinomasMiguel Taron, Yukito Ichinose, Rafael Rosell, et al.
Hematological Oncology|September 3, 2019
m7FLIPI and targeted sequencing in high-risk follicular lymphomaMarc Sorigue, Anna Oliveira, Santiago Mercadal, et al.
Pageof 7